Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Merus N.V. Common Shares Graphic](https://lunarcrush.com/gi/w:26/t:$mrus.png) Merus N.V. Common Shares (MRUS)

Genmab to acquire Merus for $X billion, sending shares soaring. Positive clinical trial data and the acquisition have driven the stock to a 1-year high.

### About Merus N.V. Common Shares
Merus N.V. Common Shares (MRUS) is a biopharmaceutical company developing cancer therapeutics.  
Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$mrus/insights)
- Merus N.V. Common Shares (MRUS) social dominance is up XXX% from the previous week.
- Merus N.V. Common Shares (MRUS) galaxy score™ is up XXXXX% from the previous week.

### Price: $XXXXX [#](/topic/$mrus/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/close.tsv)  
The XXXXX% price surge in MRUS is driven by positive clinical trial results, analyst upgrades, and high social media engagement, with the stock price currently at $84.80, hitting a 1-year high, and the positive news indicates a likely continuation of the upward trend.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXXX% | XXXXX% |

**1-Year High**: $XX on 2025-10-15  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/$mrus/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/alt_rank.tsv)  
Merus N.V. Common Shares (MRUS) is currently AltRank #478 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +321  
**1 Month**: XXX -XXX  
**6 Months**: XXX +256  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2025-08-12  
**1-Year Low**: XX on 2025-05-25  
  
  
### Galaxy Score: XXXXX [#](/topic/$mrus/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +21  
**1 Month**: XX +13  
**6 Months**: XX -XX  
**1 Year**: XX +32  
**1-Year High**: XX on 2025-07-10  
**1-Year Low**: XX on 2025-09-19  
  
  
### Engagements: XXXXX [#](/topic/$mrus/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX +283%  
**6 Months**: XXXXXXXXX +218%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-09-29  
**1-Year Low**: XXX on 2025-04-18  

| Social Network | X     | YouTube |
| -------------- | -     | ------- |
| Engagements    | XXXXX | X       |
  

  
  
### Mentions: XX [#](/topic/$mrus/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Month**: XXX +102%  
**6 Months**: XXXXX +332%  
**1 Year**: XXXXX +546%  
**1-Year High**: XXXXX on 2025-07-10  
**1-Year Low**: XX on 2024-10-21  

| Social Network | X   | YouTube |
| -------------- | -   | ------- |
| Mentions       | XXX | X       |
  

  
  
### Creators: XX [#](/topic/$mrus/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +208%  
**6 Months**: XXXXX +734%  
**1 Year**: XXXXX +738%  
**1-Year High**: XXX on 2025-09-30  
**1-Year Low**: X on 2024-10-21  

The most influential creators that mention Merus N.V. Common Shares in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | X    | XXXXXX    | X     | XXX         |
| [@AaronRosenblum5](/creator/twitter/AaronRosenblum5) | X    | XXXXX     | X     | XX          |
| [@MichelleF_Davis](/creator/twitter/MichelleF_Davis) | X    | XXXXX     | X     | XX          |
| [@PhilipHemme](/creator/twitter/PhilipHemme)         | X    | XXXXX     | X     | XX          |
| [@aipatternlab](/creator/twitter/aipatternlab)       | X    | XXXXX     | X     | XX          |
| [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | X    | XXX       | X     | XX          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XX          |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XX          |
| [@eninvs_com](/creator/twitter/eninvs_com)           | X    | XXXXX     | X     | X           |
| [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | XX   | XXX       | X     | X           |

[View More](/list/creators/$mrus/100)
  
  
### Sentiment: XX% [#](/topic/$mrus/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +40%  
**6 Months**: XX% +27%  
**1 Year**: XX% +37%  
**1-Year High**: XXX% on 2025-01-26  
**1-Year Low**: X% on 2024-11-17  

**Most Supportive Themes**
- **Positive Clinical Trial Data:** (60%) Positive clinical trial results of Merus's drug, petosemtamab, particularly its high response and survival rates in head and neck cancer patients.
- **Analyst Price Target Increases:** (20%) Several social media posts highlight analysts raising price targets for MRUS based on the promising clinical trial data.
- **Acquisition by Genmab:** (15%) Genmab is acquiring Merus for $XX per share in cash, a deal valued at $X billion.
  
**Most Critical Themes**
- **Trial Data Comparison Concerns:** (1%)  Some users are expressing concerns over comparing trial results with different patient populations and treatment contexts.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXX      | XX% | XXX     | XX% | XXX      | XX% |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXX      | XX% | XXX     | XX% | XXX      | XX% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$mrus/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.0092%  
**1 Month**: XXXXXX% +0.0024%  
**6 Months**: XXXXXX% +0.0014%  
**1 Year**: XXXXXX% +0.0067%  
**1-Year High**: XXXX% on 2025-05-25  
**1-Year Low**: XXXXXX% on 2025-09-22  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$mrus/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2025-02-14  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mrus/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$0.68%  
**1 Month**: $XXXXXXXXXXXXX +$38%  
**6 Months**: $XXXXXXXXXXXXX +$140%  
**1 Year**: $XXXXXXXXXXXXX +$100%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-10-15  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Merus N.V. Common Shares in the last XX hours

[Bitcoin Incognito (XBI)](/topic/$xbi)
[Akropolis (AKRO)](/topic/$akro)
[Strategy (MSTR)](/topic/$mstr)
[BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn)
[Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna)
[Credo Technology Group Holding Ltd Ordinary Shares (CRDO)](/topic/$crdo)
[Palantir (PLTR)](/topic/$pltr)
[Electronic Arts Inc. (EA)](/topic/electronic-arts-inc)
[AstraZeneca PLC (AZN)](/topic/$azn)

**Top topics mentioned**
In the posts about Merus N.V. Common Shares in the last XX hours

[$gmabco](/topic/$gmabco), [$gmab](/topic/$gmab), [stocks technology](/topic/stocks-technology), [stocks healthcare](/topic/stocks-healthcare), [acquisition](/topic/acquisition), [$xbi](/topic/$xbi), [$psnl](/topic/$psnl), [$8b](/topic/$8b), [$akro](/topic/$akro), [$abvx](/topic/$abvx), [stocks](/topic/stocks), [investments](/topic/investments), [$mstr](/topic/$mstr), [stocks financial services](/topic/stocks-financial-services), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [stocks communication services](/topic/stocks-communication-services), [$bmrn](/topic/$bmrn), [$rna](/topic/$rna), [$crdo](/topic/$crdo), [$pltr](/topic/$pltr), [coins defi](/topic/coins-defi), [electronic arts inc](/topic/electronic-arts-inc), [$azn](/topic/$azn), [investment](/topic/investment), [$etnb](/topic/$etnb), [$argx](/topic/$argx), [$ipsc](/topic/$ipsc), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [corporate finance](/topic/corporate-finance), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$mrk](/topic/$mrk), [$pfe](/topic/$pfe), [upside](/topic/upside), [$wolf](/topic/$wolf), [$ea](/topic/$ea), [$ibrx](/topic/$ibrx), [$bntx](/topic/$bntx), [$asnd](/topic/$asnd), [$trml](/topic/$trml), [stocks energy](/topic/stocks-energy), [$sera](/topic/$sera), [$rnaz](/topic/$rnaz), [$mnov](/topic/$mnov), [$cnce](/topic/$cnce), [tesla](/topic/tesla), [vertex protocol](/topic/vertex-protocol), [$80b](/topic/$80b), [$bmy](/topic/$bmy), [dawn protocol](/topic/dawn-protocol), [$pcvx](/topic/$pcvx), [$ptct](/topic/$ptct), [$rytm](/topic/$rytm), [$etor](/topic/$etor), [$fro](/topic/$fro), [$tmc](/topic/$tmc), [$arct](/topic/$arct), [$cart](/topic/$cart), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [ticker](/topic/ticker), [$55b](/topic/$55b), [$frmi](/topic/$frmi), [$lgo](/topic/$lgo), [advanced micro devices](/topic/advanced-micro-devices), [bank of america](/topic/bank-of-america), [stocks industrials](/topic/stocks-industrials), [$avav](/topic/$avav), [make a](/topic/make-a), [stocks real estate](/topic/stocks-real-estate), [$mlys](/topic/$mlys), [$tars](/topic/$tars), [$mtsr](/topic/$mtsr), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [costa rican colon](/topic/costa-rican-colon), [targets](/topic/targets), [combo](/topic/combo), [$nvo](/topic/$nvo), [$roiv](/topic/$roiv), [$meso](/topic/$meso), [$mltx](/topic/$mltx), [$iova](/topic/$iova), [$ewtx](/topic/$ewtx), [$prgo](/topic/$prgo), [$cort](/topic/$cort), [$cytk](/topic/$cytk), [occidental petroleum](/topic/occidental-petroleum), [$bcax](/topic/$bcax), [cere network](/topic/cere-network), [coins made in usa](/topic/coins-made-in-usa), [coins depin](/topic/coins-depin), [$oklo](/topic/$oklo), [stocks basic materials](/topic/stocks-basic-materials), [$wpm](/topic/$wpm), [$dnli](/topic/$dnli), [$hmy](/topic/$hmy), [$9700shr](/topic/$9700shr), [dp](/topic/dp), [$ymab](/topic/$ymab), [coins nft](/topic/coins-nft), [$97share](/topic/$97share), [united states dollar](/topic/united-states-dollar)

### Top Social Posts [#](/topic/$mrus/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"📈 US Exchanges 52-Week New Highs: $ATAI Atai Life Sciences N V $REKR Rekor Systems $CCO Clear Channel Outdoor $GILD Gilead Sciences $DGXX Digi Power X $ROIV Roivant Sciences $ASX Ase Industrial Holding $CVS CVS $MNST Monster Beverage $EL Estee Laudermpanies $MNMD Mind Medicine Mindmed $MRUS Merus N V CS $BG Bunge $XERS Xeris Pharmaceuticals $FIGS Figs #stockinfocus"  
[X Link](https://x.com/aipatternlab/status/1979571124909294014) [@aipatternlab](/creator/x/aipatternlab) 2025-10-18T15:31Z 4265 followers, XXX engagements


"$AZN $PFE $LLY $GILD $NVO $GSK $JNJ $GMAB $MRUS $ZLDPF $RHHBY $MTSR $ABBV $MRK $NVS $SNN $ZBH Listen to Washington J&J Orpho Spin Eyecare Merus Deal: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud"  
[X Link](https://x.com/SamFazeli8/status/1979126760215065009) [@SamFazeli8](/creator/x/SamFazeli8) 2025-10-17T10:06Z 2881 followers, XXX engagements


"#short_strategy $MSTR $DNN $MRUS $NKTR $CRDO $PLTR $UUUU"  
[X Link](https://x.com/eninvs_com/status/1978959491639996719) [@eninvs_com](/creator/x/eninvs_com) 2025-10-16T23:01Z 2528 followers, XXX engagements


"#short_strategy $MSTR $DNN $MRUS $NKTR $CRDO $PLTR $LYEL"  
[X Link](https://x.com/eninvs_com/status/1978959413420425269) [@eninvs_com](/creator/x/eninvs_com) 2025-10-16T23:01Z 2528 followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Merus N.V. Common Shares Graphic Merus N.V. Common Shares (MRUS)

Genmab to acquire Merus for $X billion, sending shares soaring. Positive clinical trial data and the acquisition have driven the stock to a 1-year high.

About Merus N.V. Common Shares

Merus N.V. Common Shares (MRUS) is a biopharmaceutical company developing cancer therapeutics.
Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • Merus N.V. Common Shares (MRUS) social dominance is up XXX% from the previous week.
  • Merus N.V. Common Shares (MRUS) galaxy score™ is up XXXXX% from the previous week.

Price: $XXXXX #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The XXXXX% price surge in MRUS is driven by positive clinical trial results, analyst upgrades, and high social media engagement, with the stock price currently at $84.80, hitting a 1-year high, and the positive news indicates a likely continuation of the upward trend.

24-Hour 7-Day 30-Day
XXXX% XXXX% XXXXX%

1-Year High: $XX on 2025-10-15
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXX #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Merus N.V. Common Shares (MRUS) is currently AltRank #478 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXX +321
1 Month: XXX -XXX
6 Months: XXX +256
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-08-12
1-Year Low: XX on 2025-05-25

Galaxy Score: XXXXX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +21
1 Month: XX +13
6 Months: XX -XX
1 Year: XX +32
1-Year High: XX on 2025-07-10
1-Year Low: XX on 2025-09-19

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +283%
6 Months: XXXXXXXXX +218%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-09-29
1-Year Low: XXX on 2025-04-18

Social Network X YouTube
Engagements XXXXX X

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Month: XXX +102%
6 Months: XXXXX +332%
1 Year: XXXXX +546%
1-Year High: XXXXX on 2025-07-10
1-Year Low: XX on 2024-10-21

Social Network X YouTube
Mentions XXX X

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1 Month: XXX +208%
6 Months: XXXXX +734%
1 Year: XXXXX +738%
1-Year High: XXX on 2025-09-30
1-Year Low: X on 2024-10-21

The most influential creators that mention Merus N.V. Common Shares in the last XX hours

Creator Rank Followers Posts Engagements
@PersimmonTI X XXXXXX X XXX
@AaronRosenblum5 X XXXXX X XX
@MichelleF_Davis X XXXXX X XX
@PhilipHemme X XXXXX X XX
@aipatternlab X XXXXX X XX
@EgidiusLambrech X XXX X XX
@NightOwlBiotech X XXXXX X XX
@BiopharmIQ X XXXXXX X XX
@eninvs_com X XXXXX X X
@TheOptionsBull2 XX XXX X X

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +40%
6 Months: XX% +27%
1 Year: XX% +37%
1-Year High: XXX% on 2025-01-26
1-Year Low: X% on 2024-11-17

Most Supportive Themes

  • Positive Clinical Trial Data: (60%) Positive clinical trial results of Merus's drug, petosemtamab, particularly its high response and survival rates in head and neck cancer patients.
  • Analyst Price Target Increases: (20%) Several social media posts highlight analysts raising price targets for MRUS based on the promising clinical trial data.
  • Acquisition by Genmab: (15%) Genmab is acquiring Merus for $XX per share in cash, a deal valued at $X billion.

Most Critical Themes

  • Trial Data Comparison Concerns: (1%) Some users are expressing concerns over comparing trial results with different patient populations and treatment contexts.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XXX XX%
YouTube X X% X X% X X%
Total XXX XX% XXX XX% XXX XX%

Social Dominance: XXXXXXX% #


Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.0092%
1 Month: XXXXXX% +0.0024%
6 Months: XXXXXX% +0.0014%
1 Year: XXXXXX% +0.0067%
1-Year High: XXXX% on 2025-05-25
1-Year Low: XXXXXX% on 2025-09-22

Market Dominance: XXXXXXX% #


Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-02-14

Market Cap: $XXXXXXXXXXXXX #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.68%
1 Month: $XXXXXXXXXXXXX +$38%
6 Months: $XXXXXXXXXXXXX +$140%
1 Year: $XXXXXXXXXXXXX +$100%
1-Year High: $XXXXXXXXXXXXX on 2025-10-15
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about Merus N.V. Common Shares in the last XX hours

Bitcoin Incognito (XBI) Akropolis (AKRO) Strategy (MSTR) BioMarin Pharmaceutical, Inc. (BMRN) Avidity Biosciences, Inc. Common Stock (RNA) Credo Technology Group Holding Ltd Ordinary Shares (CRDO) Palantir (PLTR) Electronic Arts Inc. (EA) AstraZeneca PLC (AZN)

Top topics mentioned In the posts about Merus N.V. Common Shares in the last XX hours

$gmabco, $gmab, stocks technology, stocks healthcare, acquisition, $xbi, $psnl, $8b, $akro, $abvx, stocks, investments, $mstr, stocks financial services, stocks bitcoin treasuries, stocks communication services, $bmrn, $rna, $crdo, $pltr, coins defi, electronic arts inc, $azn, investment, $etnb, $argx, $ipsc, stocks consumer cyclical, corporate finance, regeneron pharmaceuticals inc, $mrk, $pfe, upside, $wolf, $ea, $ibrx, $bntx, $asnd, $trml, stocks energy, $sera, $rnaz, $mnov, $cnce, tesla, vertex protocol, $80b, $bmy, dawn protocol, $pcvx, $ptct, $rytm, $etor, $fro, $tmc, $arct, $cart, stocks bitcoin miners, ticker, $55b, $frmi, $lgo, advanced micro devices, bank of america, stocks industrials, $avav, make a, stocks real estate, $mlys, $tars, $mtsr, akro akero therapeutics inc, costa rican colon, targets, combo, $nvo, $roiv, $meso, $mltx, $iova, $ewtx, $prgo, $cort, $cytk, occidental petroleum, $bcax, cere network, coins made in usa, coins depin, $oklo, stocks basic materials, $wpm, $dnli, $hmy, $9700shr, dp, $ymab, coins nft, $97share, united states dollar

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"📈 US Exchanges 52-Week New Highs: $ATAI Atai Life Sciences N V $REKR Rekor Systems $CCO Clear Channel Outdoor $GILD Gilead Sciences $DGXX Digi Power X $ROIV Roivant Sciences $ASX Ase Industrial Holding $CVS CVS $MNST Monster Beverage $EL Estee Laudermpanies $MNMD Mind Medicine Mindmed $MRUS Merus N V CS $BG Bunge $XERS Xeris Pharmaceuticals $FIGS Figs #stockinfocus"
X Link @aipatternlab 2025-10-18T15:31Z 4265 followers, XXX engagements

"$AZN $PFE $LLY $GILD $NVO $GSK $JNJ $GMAB $MRUS $ZLDPF $RHHBY $MTSR $ABBV $MRK $NVS $SNN $ZBH Listen to Washington J&J Orpho Spin Eyecare Merus Deal: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud"
X Link @SamFazeli8 2025-10-17T10:06Z 2881 followers, XXX engagements

"#short_strategy $MSTR $DNN $MRUS $NKTR $CRDO $PLTR $UUUU"
X Link @eninvs_com 2025-10-16T23:01Z 2528 followers, XXX engagements

"#short_strategy $MSTR $DNN $MRUS $NKTR $CRDO $PLTR $LYEL"
X Link @eninvs_com 2025-10-16T23:01Z 2528 followers, XX engagements

Merus N.V. Common Shares (MRUS)
/topic/$mrus